Replies to post #173854 on Biotech Values

[dav1234]

Yup..FDA trying to set some kind of record on MNTA mcopax review..there really needs to be some kind pdufa like timeline for this stuff..

[DewDiligence]

4Q13 US Copaxone sales were $805M, +1% QoQ and -2% YoY:

http://www.sec.gov/Archives/edgar/data/818686/000119312514038744/d672475dex991.htm

[jbog]

polly,

If you consider that Copaxone had a 10% price increase coupled with a 1% yoy decrease I wouldn't call it exactly minimal this early in the oral game.

Hopefully we'll never know.